Trial Profile
Mechanisms of Immune Reconstitution and Reduced Immune Activation Following Darunavir-based ART
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 12 Jan 2017 Status changed from recruiting to completed.
- 25 Jun 2013 New trial record